| scholarly article | Q13442814 |
| P50 | author | Kevork M. Peltekian | Q42939206 |
| P2093 | author name string | Michael Grant | |
| Maureen Gallant | |||
| Lisa Barrett | |||
| M Ian Bowmer | |||
| Geri Hirsch | |||
| Constance Howley | |||
| P2860 | cites work | Binding of hepatitis C virus to CD81 | Q22004178 |
| Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 | ||
| Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity | Q24300867 | ||
| Isolation of the thrombospondin membrane receptor | Q24314835 | ||
| Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway | Q24524076 | ||
| Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex | Q24537657 | ||
| Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines | Q24605501 | ||
| Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway | Q24678596 | ||
| Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
| Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients | Q27469952 | ||
| Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses | Q27472844 | ||
| Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection | Q27472915 | ||
| Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein | Q27485143 | ||
| Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions | Q27485145 | ||
| Interleukin-10 determines viral clearance or persistence in vivo | Q27486832 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion | Q28115526 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| Anti-immunology: evasion of the host immune system by bacterial and viral pathogens | Q28298920 | ||
| CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis | Q28678344 | ||
| CD36 is a receptor for oxidized low density lipoprotein | Q28678362 | ||
| CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3) | Q28678493 | ||
| Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 | ||
| Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease | Q29614208 | ||
| Replication of hepatitis C virus | Q29620645 | ||
| Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection | Q29620795 | ||
| Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response | Q29620891 | ||
| Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway | Q30308176 | ||
| Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation | Q30434118 | ||
| Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. | Q30473065 | ||
| Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape | Q33843371 | ||
| Viral mechanisms of immune evasion | Q34011092 | ||
| Recent advances in the molecular biology of hepatitis C virus | Q34417709 | ||
| Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism | Q35024327 | ||
| Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells | Q36228153 | ||
| Virology of hepatitis B and C viruses and antiviral targets | Q36336128 | ||
| Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation | Q36371776 | ||
| A role for CD36 in the regulation of dendritic cell function | Q37113896 | ||
| Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells. | Q38310502 | ||
| The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells | Q38585283 | ||
| Human monocyte CD14 is upregulated by lipopolysaccharide. | Q39824929 | ||
| Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus | Q40588817 | ||
| An investigation of incorporation of cellular antigens into vaccinia virus particles | Q40703341 | ||
| Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain | Q41513603 | ||
| Hepatitis C: the clinical spectrum of disease | Q41598735 | ||
| Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa | Q42977701 | ||
| Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. | Q42981482 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Effects of antiviral therapy on the cellular immune response in acute hepatitis C. | Q42986125 | ||
| Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection | Q42987223 | ||
| Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals | Q42993342 | ||
| Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders | Q42997948 | ||
| Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. | Q42998720 | ||
| Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells | Q42999644 | ||
| Circulating IL-2 and IL-10 in chronic active hepatitis C with respect to the response to IFN treatment | Q43000925 | ||
| Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. | Q43033205 | ||
| Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms. | Q43036310 | ||
| Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy | Q43041935 | ||
| Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. | Q43048494 | ||
| Detection of functionally altered hepatitis C virus-specific CD4+ T cells in acute and chronic hepatitis C | Q43048770 | ||
| Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection | Q43048886 | ||
| The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations | Q43049266 | ||
| Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages | Q43612846 | ||
| Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. | Q44598571 | ||
| Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection | Q45722071 | ||
| Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients | Q45739617 | ||
| Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol | Q46562665 | ||
| Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. | Q47873176 | ||
| Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor | Q47888299 | ||
| Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. | Q53561084 | ||
| Structural biology of hepatitis C virus | Q56762917 | ||
| Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study | Q60216395 | ||
| Monocytes are target cells for IL-10 induction by HIV-1 Nef protein | Q73053426 | ||
| Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-gamma is elevated in patients with hepatitis C infection | Q73561521 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 28 | |
| P577 | publication date | 2008-06-13 | |
| P1433 | published in | BMC Immunology | Q2877163 |
| P1476 | title | Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals | |
| P478 | volume | 9 |
| Q33489565 | Anatomy of viral persistence |
| Q34795394 | Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. |
| Q100385905 | Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C |
| Q42014328 | Distribution and characterization of IL-10-secreting cells in lymphoid tissues of PCV2-infected pigs |
| Q36055483 | Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection |
| Q31127335 | Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study |
| Q51898059 | Immunosuppressive mechanisms during viral infectious diseases. |
| Q37775279 | Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus |
| Q34450690 | Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo |
| Q30386590 | Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins |
| Q43035061 | Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections |
| Q42986592 | The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection |
| Q36794134 | The anti-idiotypic antibody 1F7 stimulates monocyte interleukin-10 production and induces endotoxin tolerance |
| Q35099024 | Unique Cytokine/Chemokine Signatures for HIV-1 and HCV Mono-infection versus Co-infection as Determined by the Luminex® Analyses |
Search more.